CRC, Jan Waldenströms gata 35, 60-13
SUS Malmö
SE-205 02  Malmö


+46 40 391233


Tanja Stocks

Associate researcher

Academic degree

PhD, Umeå University, Sweden, June 2009. Title: Metabolic factors and cancer risk; Prospective studies on prostate cancer, colorectal cancer and cancer overall.

BSc in Dietetics, Umeå University, Sweden, 2002

BSc in Sports Pedagogics, Umeå University, Sweden, 2002

Current position

Associate researcher at Lund University, Dept of Clinical Sciences in Malmö, Diabetes and cardiovascular disease - genetic epidemiology. Feb 2014-present.

Previous academic positions

Postdoc. Umeå University, Dept of Surgical and Perioperative Sciences, Urology and Andrology. Topic: Metabolic risk factors and cancer risk. July 2009 - Jan 2014.

Postdoc. Institute of Preventive Medicine, Frederiksberg, Denmark. Topic: Gene-diet interactions in obesity. Sept 2010 - April 2013.

Postdoc. Amsterdam Free University, Institute of Health Sciences, Amsterdam, the Netherlands. Topic: Childhood growth and subsequent obesity. Oct 2009 - July 2010.

Research interests

Cancer epidemiology, in particular metabolic and genetic risk factors in relation to risk and prognosis of cancer. Diabetes, obesity and cardiovascular diseases; their determinants and their associations with risk of cancer.

Ongoing projects

Metabolic factors and risk for various cancers in the Metabolic Syndrome and Cancer project (Me-Can) (PI)

Mendelian randomization studies of lipids and cancer risk in the Malmö Diet and Cancer Study

Metabolic factors, genetic variants and risk and prognosis of cancers of the prostate and urinary bladder using several Swedish cohorts and national registries.

Ongoing grants

Swedish Research Council (2016-2018)
Nordic Cancer Union (2017)
Crafoord Foundation (2017-2018)
MAS Cancer Foundation (2017)


Fifty-one publications indexed in PubMed, H-factor 21 (Sept 2017)

Selected publications

Orho-Melander M, Hindy G, Borgquist S, Schulz CA, Manjer J, Melander O, Stocks T. Blood lipid genetic scores, the HMGCR gene, and cancer risk: a Mendelian randomization study. Accepted in Int J Epidemiol.

Stocks T, Ängquist L, Hager J, Charon C, Holst C, Martinez JA, Saris WH, Astrup A, Sørensen TIA, Larsen LH. TFAP2B-dietary protein and glycemic index interactions and weight maintenance after weight loss in the DiOGenes trial. Hum Hered, 2013:75(2-4):213-9.

Stocks T, Van Hemelrijck M, Manjer J, Bjørge T, Ulmer H, Hallmans G, Lindkvist B, Selmer R, Nagel G, Tretli S, Concin H, Engeland A, Jonsson H, Stattin P. Blood pressure and risk of cancer incidence and mortality in the Metabolic syndrome and Cancer project (Me-Can). Hypertension, 2012 Feb 21.

Stocks T, Renders CM, Bulk-Bunschoten AMW, Hirasing RA, van Buuren S, Seidell JC. Body size and growth in 0-4 year old children and the relation to body size in primary school age. Obesity Reviews, 2011 Mar 23.

Stocks T, Lukanova A, Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierød MB, Jonsson H, Stattin P. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer, 2010 Dec 17.

Stocks T, Rapp K, Bjørge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Johansen D, Concin H, Tretli S, Hallmans G, Jonsson H, Stattin P. Blood glucose and risk of incident and fatal cancer in the Metabolic syndrome and Cancer project (Me-Can). PLoS Medicine. 2009 Dec 22.

Last updated: October 13, 2016
Website contact: LUDC webteam

LUDC, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00